Last edition
News about "Hikal"
Hikal Limited Shows Resilient Performance Amid Industry Headwinds
Hikal’s Panolisite undergone US FDA audit which was concluded with ‘Zero’ 483 observations. US FDA approval is in line with de-risking strategy for additional API site to service our global customer base.
Hikal | 10/08/2023 | By Manvi | 342
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members